BackInovio Pharmaceuticals Overview
Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Target Price

Analysts' average 12-month price target for Inovio Pharmaceuticals is $2.8.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.18

Average Target Price

$2.75133.1% upside

2 analysts in the last 4 months

High: $3 | Low: $2.5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13Jefferies$3154.2% upsideOpen
2026-06-01H.C. Wainwright$2.5111.9% upsideOpen
2025-11-14Piper SandlerEdward Tenthoff$6408.5% upsideOpen
2024-08-09RBC CapitalGregory Renza$8578% upsideOpen
2024-05-14OppenheimerHartaj Singh$403289.8% upsideOpen
2024-05-13StephensSudan Loganathan$201594.9% upsideOpen
2024-01-25OppenheimerHartaj Singh$4239% upsideOpen

Inovio Pharmaceuticals (INO) FAQ

As of the most recent data, INO shows a target price of $2.8. Scroll down for historical charts and peer comparison views.

If Inovio Pharmaceuticals moved to the average analyst target of $2.8, shares would be roughly 133.1% higher than $1.18. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Inovio Pharmaceuticals's earnings trajectory.

Besides this target price page, Stockcircle has Inovio Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $2.8) with ownership activity and broader fundamentals.

Inovio Pharmaceuticals's target price is $2.8; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.